Dr. Llanos on Genetic Disparities in Cancer Care


Adana A.M. Llanos, PhD, MPH, discusses disparities in genetic research in cancer care.

Adana A.M. Llanos, PhD, MPH, cancer and molecular epidemiologist, Mailman School of Public Health, Columbia University, adjunct associate professor, Rutgers School of Public Health, discusses disparities in genetic research in cancer care.

When considering emerging data and ongoing studies evaluating the genetics of patients with cancer, such as triple-negative breast cancer (TNBC), limitations still exist regarding this research, Llanos says. Racial and ethnic minority groups, specifically those of African ancestry, have been underrepresented in prior research into the genetics of cancer, Llanos explains.

Broad representation in new and future studies will be critical, Llanos adds. Expanding research to provide a more inclusive look at genetic and etiological differences in patients will provide a clearer picture as to how they can affect treatment, Llanos concludes.

Related Videos
Jaime R. Merchán, MD, Sylvester Comprehensive Cancer Center
Rona Yaeger, MD
Jeremy L. Ramdial, MD, assistant professor, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Alexandra Gomez Arteaga, MD, Weill Cornell Medicine/New York-Presbyterian Hospital
Rahul Banerjee, MD, FACP, assistant professor, Clinical Research Division, Fred Hutchinson Cancer Center; assistant professor, Division of Hematology and Oncology, University of Washington
Alice Bertaina, MD, PhD
Jeffery Auletta, MD, The Ohio State University College of Medicine
Betty Hamilton, MD, Cleveland Clinic
Stephanie Lee, MD, MPH, Fred Hutchinson Cancer Center
Chul Kim, MD, MPH